PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummarySep 24, 2002	Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form Plainsboro, New Jersey, September 24, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing the Helitene&reg;	View HTML Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form 12.5 KB
Toggle SummaryOct 13, 2003	Integra NeuroSciences Donates Camino® Monitoring Systems and LICOX® Brain Tissue Oxygen Monitoring System to US Army Hospital in Iraq Integra NeuroSciences Donates Camino® Monitoring Systems and LICOX® Brain Tissue Oxygen Monitoring System to US Army Hospital in Iraq Plainsboro, New Jersey, October 13, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today responded to a request from the 207th Neurosurgery Team at	View HTML Integra NeuroSciences Donates Camino® Monitoring Systems and LICOX® Brain Tissue Oxygen Monitoring System to US Army Hospital in Iraq 9.7 KB
Toggle SummaryOct 12, 2005	Integra NeuroSciences Features AccuDrain External CSF Drainage System at the Congress of Neurological Surgeons Annual Meeting Integra NeuroSciences Features AccuDrain External CSF Drainage System at the Congress of Neurological Surgeons Annual Meeting PLAINSBORO, N.J., Oct. 12, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it is featuring the AccuDrain™ External CSF Drainage	View HTML Integra NeuroSciences Features AccuDrain External CSF Drainage System at the Congress of Neurological Surgeons Annual Meeting 12.8 KB
Toggle SummaryAug 31, 2009	Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery PLAINSBORO, N.J., Aug 31, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is featuring the MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System at the XIV World Congress of Neurological Surgery in Boston, Massachusetts, August 30	View HTML Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery 18 KB
Toggle SummaryOct 10, 2005	Integra NeuroSciences Features the Integra NPH Low Flow Hydrocephalus Valve at the Congress of Neurological Surgeons Annual Meeting Integra NeuroSciences Features the Integra NPH Low Flow Hydrocephalus Valve at the Congress of Neurological Surgeons Annual Meeting PLAINSBORO, N.J., Oct. 10, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) is featuring the Integra NPH™ Low Flow Hydrocephalus Valve	View HTML Integra NeuroSciences Features the Integra NPH Low Flow Hydrocephalus Valve at the Congress of Neurological Surgeons Annual Meeting 13 KB
Toggle SummaryOct 20, 2003	Integra NeuroSciences Launches DuraGen PlusT Dural Graft Matrix Integra NeuroSciences Launches DuraGen PlusT Dural Graft Matrix Plainsboro, New Jersey, October 20, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market	View HTML Integra NeuroSciences Launches DuraGen PlusT Dural Graft Matrix 10.6 KB
Toggle SummarySep 16, 2007	Integra NeuroSciences Launches DuraGen XS Dural Regeneration Matrix PLAINSBORO, N.J., Sep 16, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market the DuraGen XS(TM) Dural	View HTML Integra NeuroSciences Launches DuraGen XS Dural Regeneration Matrix 17.5 KB
Toggle SummaryOct 20, 2003	Integra NeuroSciences Launches EnDura? No-React® Dural Substitute Integra NeuroSciences Launches EnDura™ No-React® Dural Substitute Plainsboro, New Jersey, October 20, 2003 -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced plans to market and sell EnDura™ No-React&reg; Dural Substitute, a new suturable product for repair of the dura	View HTML Integra NeuroSciences Launches EnDura™ No-React® Dural Substitute 10.6 KB
Toggle SummarySep 8, 2004	Integra NeuroSciences Launches NeuraWrap Nerve Protector Integra NeuroSciences Launches NeuraWrap(TM) Nerve Protector PLAINSBORO, N.J., Sept. 8, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has received 510(k) clearance from the United States Food and Drug Administration to market	View HTML Integra NeuroSciences Launches NeuraWrap(TM) Nerve Protector 11.5 KB
Toggle SummaryOct 15, 2004	Integra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System Integra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System PLAINSBORO, N.J., Oct. 15, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it plans to market and sell the NeuroSensor Cerebral Blood Flow and	View HTML Integra NeuroSciences Launches NeuroSensor Cerebral Blood Flow and Intracranial Pressure System 11.7 KB